Methods and compositions for modulating adipocyte function
AssigneesChildren's Hospital Boston, Joslin Diabetes Center, Inc.
InventorsC. Ronald Kahn, Yu-Hua Tseng, Atul Butte
Life of this patent
Estimating the term…
Abstract
Methods and compositions for treating obesity and related disorders. The methods include the use of BMP-2, -4, -6 and -7.
Claims18
1-10. (canceled)
A method of identifying a candidate therapeutic agent for the treatment of obesity, the method comprising:
- providing a non-human animal model of obesity;
- administering to the animal one or more agent that increases the expression or activity of a member selected from the group consisting of:
- BMP-2, BMP-4, BMP-5, BMP-6 and BMP-7;
- and evaluating the effect of the one or more agent on obesity in the animal model, wherein an agent that decreases obesity in the animal model is a candidate therapeutic agent for the treatment of obesity.
(canceled)
15-18. (canceled)
A method of decreasing fat stores or weight in a subject, the method comprising identifying a subject in need of decreasing fat stores or weight, and administering a composition to the subject, wherein the composition comprises a therapeutically effective amount of an agent that increases bone morphogenetic protein 7 (BMP-7) signaling, in an amount sufficient to promote BAT differentiation.
A method of decreasing fat stores or weight in a subject, the method comprising identifying a subject in need of decreasing fat stores or weight, and administering a composition to the subject, wherein the composition comprises a therapeutically effective amount of one or more agent that increases signaling of a bone morphogenic protein selected from the group consisting of:
- (a) bone morphogenetic protein 2 (BMP-2);
- (b) bone morphogenetic protein 4 (BMP-4);
- (c) bone morphogenetic protein 5 (BMP-5);
- and (d) bone morphogenetic protein 6 (BMP-6), in an amount sufficient to promote BAT differentiation.
A method of therapeutically and/or prophylactically treating obesity comprising identifying a subject in need of treating obesity, and administering a composition to the subject, wherein the composition comprises a therapeutically effective amount of one or more agent that increases signaling of a bone morphogenic protein selected from the group consisting of:
- (a) bone morphogenetic protein 2 (BMP-2);
- (b) bone morphogenetic protein 4 (BMP-4);
- (c) bone morphogenetic protein 5 (BMP-5);
- (d) bone morphogenetic protein 6 (BMP-6);
- and (e) bone morphogenic protein 7 (BMP-7), in an amount sufficient to promote BAT differentiation.
A method for the therapeutically and/or prophylactically treating obesity comprising identifying a subject in need of treating and/or preventing obesity, and administering a composition to the subject, wherein the composition comprises a therapeutically or prophylactically effective amount of one or more agent that increases signaling of a bone morphogenic protein selected from the group consisting of:
- bone morphogenic protein 2 (BMP-2);
- bone morphogenic protein 4 (BMP-4);
- bone morphogenic protein 5 (BMP-5);
- bone morphogenic protein 6 (BMP-6);
- and bone morphogenic protein 7 (BMP-7).
An in vitro method of promoting differentiation of preadipocyte or adipocyte cells into brown adipocyte tissue (BAT), the method comprising contacting a preadipocyte or adipocyte cell or tissue with one or more agent that increases signaling of a bone morphogenic protein selected from the group consisting of:
- bone morphogenic protein 2 (BMP-2);
- bone morphogenic protein 4 (BMP-4);
- bone morphogenic protein 5 (BMP-5);
- bone morphogenic protein 6 (BMP-6);
- and bone morphogenic protein 7 (BMP-7) in an amount sufficient to promote BAT differentiation;
- and evaluating BAT differentiation in the differentiated cell or tissue by measuring a marker of BAT differentiation.
A method for providing a cell culture enriched in brown adipocytes, the method comprising:
- providing a plurality of preadipocyte or adipocyte cells in vitro;
- contacting the plurality of cells with a composition comprising one or more member selected from the group consisting of:
- (a) bone morphogenic protein 2 (BMP-2);
- (b) bone morphogenic protein 4 (BMP-4);
- (c) bone morphogenic protein 5 (BMP-5);
- (d) bone morphogenic protein 6 (BMP-6);
- and (e) bone morphogenic protein 7 (BMP-7), in an amount sufficient to promote BAT differentiation;
- and evaluating BAT differentiation in the culture, by measuring uncoupling protein-1 expression, wherein an increase in uncoupling protein-1 expression indicates an increase in BAT differentiation, thereby providing a culture enriched in brown adipocytes.
Dependencies are inferred from the claim text.